PERI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 35.192
EU - Europa 20.688
AS - Asia 10.821
SA - Sud America 1.525
AF - Africa 273
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 20
Totale 68.555
Nazione #
US - Stati Uniti d'America 34.640
DE - Germania 5.620
SE - Svezia 4.592
SG - Singapore 3.356
DK - Danimarca 2.820
IT - Italia 2.699
CN - Cina 2.507
VN - Vietnam 1.804
HK - Hong Kong 1.305
RU - Federazione Russa 1.205
BR - Brasile 1.187
IE - Irlanda 630
GB - Regno Unito 547
FR - Francia 535
UA - Ucraina 534
PL - Polonia 412
IN - India 405
CA - Canada 398
FI - Finlandia 244
AT - Austria 237
KR - Corea 201
NL - Olanda 184
BD - Bangladesh 176
ID - Indonesia 158
TR - Turchia 142
JP - Giappone 124
IQ - Iraq 123
ES - Italia 112
AR - Argentina 101
BE - Belgio 98
PK - Pakistan 95
MX - Messico 92
ZA - Sudafrica 88
SA - Arabia Saudita 55
EC - Ecuador 54
PH - Filippine 48
CO - Colombia 47
UZ - Uzbekistan 42
CH - Svizzera 40
VE - Venezuela 40
CL - Cile 37
RO - Romania 36
MY - Malesia 32
MA - Marocco 31
LT - Lituania 29
EG - Egitto 28
AU - Australia 27
IR - Iran 27
TW - Taiwan 26
KE - Kenya 24
AE - Emirati Arabi Uniti 23
PY - Paraguay 23
ET - Etiopia 22
JO - Giordania 21
NP - Nepal 21
TN - Tunisia 21
IL - Israele 19
DZ - Algeria 18
AZ - Azerbaigian 17
CZ - Repubblica Ceca 15
PT - Portogallo 15
GR - Grecia 14
PE - Perù 13
EU - Europa 12
LB - Libano 12
TH - Thailandia 12
DO - Repubblica Dominicana 10
JM - Giamaica 10
UY - Uruguay 10
AL - Albania 9
BO - Bolivia 9
HU - Ungheria 8
KZ - Kazakistan 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
OM - Oman 8
PS - Palestinian Territory 8
BB - Barbados 7
BG - Bulgaria 7
CR - Costa Rica 7
KG - Kirghizistan 7
LV - Lettonia 7
PA - Panama 7
RS - Serbia 7
MU - Mauritius 6
SY - Repubblica araba siriana 6
TT - Trinidad e Tobago 6
MD - Moldavia 5
NG - Nigeria 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
AO - Angola 4
BY - Bielorussia 4
GE - Georgia 4
GY - Guiana 4
SC - Seychelles 4
SN - Senegal 4
BH - Bahrain 3
CI - Costa d'Avorio 3
CY - Cipro 3
Totale 68.486
Città #
Ann Arbor 19.992
Frankfurt am Main 5.173
Stockholm 3.745
Singapore 1.888
Ashburn 1.562
Hong Kong 1.252
Woodbridge 1.151
Wilmington 1.092
San Jose 976
Chandler 942
Fairfield 884
Milan 841
Houston 617
Dublin 603
Jacksonville 507
Ho Chi Minh City 493
Seattle 373
Hanoi 367
Beijing 348
Santa Clara 337
Kraków 329
Dearborn 311
Los Angeles 288
New York 280
Rome 271
Hefei 270
Chicago 269
Cambridge 268
Princeton 232
Dong Ket 220
Vienna 210
Council Bluffs 208
Nanjing 191
Seoul 181
The Dalles 179
Dallas 162
Shanghai 154
Boardman 147
São Paulo 137
Altamura 131
Guangzhou 131
Lauterbourg 121
Toronto 121
Jakarta 120
Buffalo 113
Lawrence 107
Helsinki 103
Tokyo 89
Brussels 85
San Diego 82
Lachine 80
Moscow 80
Orem 74
Florence 59
Munich 59
London 58
Chennai 56
Amsterdam 54
Warsaw 54
Da Nang 53
Ottawa 50
Montreal 49
Hangzhou 48
Johannesburg 47
Brooklyn 46
Hyderabad 46
Jinan 46
Baghdad 45
Fremont 45
Haiphong 45
Tianjin 44
Denver 42
Falls Church 42
Phoenix 41
Montréal 39
Shenyang 39
Tashkent 39
Hebei 38
Nuremberg 38
Turin 38
Atlanta 37
Nanchang 37
Rio de Janeiro 37
Andover 36
Dhaka 36
Changsha 35
Paris 34
Brasília 31
Biên Hòa 29
Huizen 29
Kent 29
Manchester 29
Piscataway 29
Brescia 28
Norwalk 28
Salt Lake City 28
San Francisco 28
Can Tho 27
Columbus 27
Ha Long 27
Totale 50.768
Nome #
Representative secondary PET micro and nanoplastics via ethylene glycol fragmentation (EGF): Physicochemical and immuno-toxicological properties 1.925
Validating Natural Compounds as Toll-Like Receptor 4 (TLR4) Antagonists: Experimental Challenges and Therapeutic Perspectives 1.903
Novel carboxylate-based glycolipids: TLR4 antagonism, MD-2 binding and self-assembly properties 824
Synthetic and natural small molecule TLR4 antagonists inhibit motoneuron death in cultures from ALS mouse model 794
Toll-like receptor 4 modulation influences human neural stem cell proliferation and differentiation 787
Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists 785
Selective cytotoxicity of a bicyclic Ras inhibitor in cancer cells expressing K-RasG13D 733
Structural characterization of aerogels derived from enzymatically oxidized galactomannans of fenugreek, sesbania and guar gums 728
Amphiphilic Guanidinocalixarenes Inhibit Lipopolysaccharide (LPS)-and Lectin-Stimulated Toll-like Receptor 4 (TLR4) Signaling 719
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection 703
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives 691
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line 679
First experimental identification of Ras-inhibitor binding interface using a water-soluble Ras ligand 676
Dye-sensitized photocatalytic hydrogen production: Distinct activity in a glucose derivative of a phenothiazine dye 675
Functional characterization of E. coli LptC: Interaction with LPS and a synthetic ligand 669
The Role of TLR4 in Neural Stem Cells–Mediated Neurogenesis and Neuroinflammation 665
Co-administration of Antimicrobial Peptides Enhances Toll-like Receptor 4 Antagonist Activity of a Synthetic Glycolipid 649
The Multi-Level Mechanism of Action of a Pan-Ras Inhibitor Explains its Antiproliferative Activity on Cetuximab-Resistant Cancer Cells 648
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 641
The role of carbohydrates in the lipopolysaccharide (LPS)/toll-like receptor 4 (TLR4) Signalling 632
Synthesis of the New Cyanine-Labeled Bacterial Lipooligosaccharides for Intracellular Imaging and in Vitro Microscopy Studies 629
Glucose-derived Ras pathway inhibitors: evidence of Ras-ligand binding and Ras-GEF (Cdc25) interaction inhibition 625
Modulation of CD14 and TLR4·MD-2 activities by a synthetic lipid A mimetic 625
Dye-Sensitized Photocatalytic Hydrogen Generation: Efficiency Enhancement by Organic Photosensitizer-Coadsorbent Intermolecular Interaction 624
Binding properties and biological characterization of new sugar-derived Ras ligands 618
Glycolipids and benzylammonium lipids as novel antisepsis agents: Synthesis and biological characterization 608
Structure and inflammatory activity of the LPS isolated from Acetobacter pasteurianus CIP103108 606
Exploring the LPS/TLR4 signal pathway with small molecules 602
Metabolism of Phosphatidylinositol 4-Kinase IIIα-Dependent PI4P Is Subverted by HCV and Is Targeted by a 4-Anilino Quinazoline with Antiviral Activity 597
Glycolipid-based TLR4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties 593
Uniform lipopolysaccharide (LPS)-loaded magnetic nanoparticles for the investigation of LPS-TLR4 signaling 591
Trehalose- and glucose-derived glycoamphiphiles: Small-molecule and nanoparticle toll-like receptor 4 (TLR4) modulators 588
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update 586
Structure-Activity Studies on Arylamides and Arysulfonamides Ras Inhibitors 584
Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice 583
A Synthetic Lipid A Mimetic Modulates Human TLR4 Activity 576
Hemin and a metabolic derivative coprohemin modulate the TLR4 pathway differently through different molecular targets 574
Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis 573
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists 572
TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis 562
Synthesis and biological evaluation of novel lipid A antagonists 559
The cationic amphiphile 3,4-bis (tetradecyloxy) benzylamine inhibits LPS signaling by competing with endotoxin for CD14 binding 554
Synthetic molecules and functionalized nanoparticles targeting the LPS-TLR4 signaling: a new generation of immunotherapeutics 550
How do viruses interfere with Toll-like receptor 4? 545
A new isoluminol reagent for chemiluminescence labeling of proteins 543
Sugar-derived Ras inhibitors: Group epitope mapping by NMR spectroscopy and biological evaluation 533
Inhibition of lipid A stimulated activation of human dendritic cells and macrophages by amino and hydroxylamino monosaccharides 528
Evidence of a specific interaction between new synthetic antisepsis agents and CD14 528
Design and characterisation of a new class of inhibitors of Ras activation 523
Modulation of LPS signaling through TLR4 agonists and antagonists 523
The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling 522
Design, Synthesis and Biological Evaluation of Levoglucosenone-derived Ras Activation Inhibitors 512
Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof 509
Rigid polycycles and peptidomimetics from carbohydrate synthons 508
Multivalent glycoconjugates as anti-pathogenic agents 507
Clustered carbohydrates in synthetic vaccines 506
Optimizing operating conditions and electrochemical characterization of glucose-gluconate alkaline fuel cells 501
Carbohydrate-based bioactive compounds for medicinal chemistry applications 500
Design, synthesis and biological evaluation of sugar-derived Ras inhibitors 496
Arabinose-derived Bicyclic Amino Acids: Synthesis, Conformational Analysis and Construction of an avb3-selective RGD Peptide 490
Editorial 490
NEW SYNTHETIC AGONISTS OF TLR4 RECEPTOR 484
Glycoconjugates in cancer therapy 484
Chemoselective neoglycosylation 483
Novel α-conotoxin from Conus spurius and the α-conotoxin EI share high-affinity potentiation and low-affinity inhibition of nicotinic acetylcoline receptors 482
Carbohydrate Scaffolds for the Production of Bioactive Compounds 481
Chemistry of lipid a: At the heart of innate immunity 478
Looking forward: A glance into the future of organic chemistry 471
A novel small molecule TLR4 antagonist (IAXO-102) negatively regulates non-hematopoietic toll like receptor 4 signalling and inhibits aortic aneurysms development 471
Synthesis and biological evaluation of an anticancer vaccine containing the C-glycoside analogue of the Tn epitope 467
Clicked and long spaced galactosyl- and lactosylcalix[4]arenes: New multivalent galectin-3 ligands 466
Polycyclic Scaffolds from Fructose 464
Studies on the mechanism of action of a new class of inhibitors of Ras activation 463
Glycoconjugate and oligosaccharide mimetics by chemoselective ligation 462
Sugar-derived amino acids: powerful secondary structure inducing elements in the design of novel peptidomimetics 462
Sugar-Based Inhibitors of Ras Activation: Biological Activity and Identification of Ras–Inhibitor Binding Interface 459
Synthesis of imino sugar scaffolds for the generation of glycosidase inhibitor libraries 458
Extending chemoselective ligation to sugar chemistry:convergent assembly of bioactive neoglycoconjugates 455
Solution and solid-phase chemoselective synthesis of (1-6)-amino(methoxy) di- and trisaccharide analogues 454
Chemoselective Ligation in Glycochemistry 453
Synthesis of imino-C-disaccharides related to sucrose 451
Synthesis of bicyclic sugar azido acids and their incorporation in cyclic peptides 450
Molecular simplification of lipid A structure: TLR4-modulating cationic and anionic amphiphiles 448
Assembly of binding loops on aromatic templates as V CAM-1 mimetics 447
Conversion of lactose into mimics of N-acetyllactosamine 444
Carbohydrate-based Scaffolds for the generation of sortiments of bioactive compounds 443
A new procedure for the synthesis of C-glycosides of nojirimycin 441
Discrimination Properties of Tetraamidic Branched Selectors 439
The EuroSciCon's 2015 Innate Immunity Summit 439
Lipid A antagonists with anti-septic shock, anti-inflammatory, anti-ischemia and analgesic activity 436
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants 436
Chemoselective glycosylation techniques for the synthesis of bioactive neoglycoconjugates, glyconanoparticles and glycoarrays 434
Stereoselective synthesis of α-C-glycosides of N-acetylgalactosamine 432
Stepwise synthesis and structural characterization of calix[4]- and calix[5]arenes bearing a functionalized arm on the methylene bridge 430
Regioselection and orthogonality of the 1-phenyl-3-butenyl (PBU) protecting group in glucopyranosides 429
D-glucose as a regioselectively addressable scaffold for combinatorial chemistry on solid phase 429
Green and Roasted Coffee Extracts Inhibit Interferon-β Release in LPS-Stimulated Human Macrophages 427
Tin-mediated regioselective acylation of unprotected sugars on solid phase 424
The bone morphogenic protein antagonist Drm/gremlin is a novel pro- angiogenic factor 422
Glycidic scaffolds in Peptidomimetic synthesis 421
Totale 56.988
Categoria #
all - tutte 156.088
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 156.088


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.065 0 0 0 0 0 0 0 0 0 0 816 1.249
2021/202211.080 1.142 1.083 967 1.112 887 869 785 847 676 868 787 1.057
2022/20238.296 1.376 1.724 1.100 997 928 1.111 161 295 250 175 104 75
2023/20242.842 84 188 345 160 351 433 448 141 184 86 110 312
2024/20256.194 324 548 455 326 461 300 334 353 588 926 547 1.032
2025/202617.777 1.885 981 1.133 1.638 1.611 788 2.028 676 1.588 5.207 242 0
Totale 69.957